In The News
Clyde & Co sued by insurers over indemnity advice
Cornwalls hits back at $4.8M negligence suit by former client
‘Our integrations are on track’: Class action flags WiseTech response to short seller report
Russells partner accused of bullying told lawyer she was ‘very negative’
Top silk to join NSW Supreme Court
NAB accused of rescinding job offer to pregnant employee
Ex-Bulldogs player must produce messages between solicitor and doctor
Child removal class actions launched against NSW, WA
Slater & Gordon denies firing HR head for reporting underpayments
Wealth guru Dominique Grubisa pleads ignorance in appeal of $6M penalty
Please login to bookmarkClose

The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au